Skip to main content
Top
Published in: Cardiovascular Intervention and Therapeutics 2/2011

01-05-2011 | Case Report

The potential of surgical strategy for incomplete stent apposition after implantation of a sirolimus eluting stent

Authors: Toshiyuki Nagai, Masaru Shibata, Satoru Suzuki, Takashi Matsubara

Published in: Cardiovascular Intervention and Therapeutics | Issue 2/2011

Login to get access

Abstract

Sirolimus-eluting stents (SES) had been implanted in the left anterior descending artery of a 77-year-old male. Three years later, he was admitted for ST elevation myocardial infarction caused by stent thrombosis accompanied with incomplete stent apposition (ISA), and balloon angioplasty had to be performed on him. However, 6 months later, he was admitted for angina. There was progression of ISA and severe stenosis. Considering the allergic reaction to the polymer of the SES, or the risk of future stent thrombosis, coronary artery bypass grafting was selected for the revascularization. One year after the procedure, he felt no symptoms and the bypass graft was patent. A surgical strategy may be considered for recurrence of coronary events accompanied with ISA after stent implantation.
Literature
1.
go back to reference Ujiie Y, Hirosaka A, Mitsugi M, Ohwada T, Igarashi M, Kijima M, Komatsu N, Hisa S, Abe Y, Tsuda T, et al. Effects of angiotensin-converting enzyme inhibitors or an angiotensin receptor blocker in combination with aspirin and cilostazol on in-stent restenosis. Int Heart J. 2006;47(2):173–84.PubMedCrossRef Ujiie Y, Hirosaka A, Mitsugi M, Ohwada T, Igarashi M, Kijima M, Komatsu N, Hisa S, Abe Y, Tsuda T, et al. Effects of angiotensin-converting enzyme inhibitors or an angiotensin receptor blocker in combination with aspirin and cilostazol on in-stent restenosis. Int Heart J. 2006;47(2):173–84.PubMedCrossRef
2.
go back to reference Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315–23.PubMedCrossRef Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315–23.PubMedCrossRef
3.
go back to reference Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221–31.PubMedCrossRef Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221–31.PubMedCrossRef
4.
go back to reference Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109(6):701–5.PubMedCrossRef Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109(6):701–5.PubMedCrossRef
5.
go back to reference McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364(9444):1519–21.PubMedCrossRef McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364(9444):1519–21.PubMedCrossRef
6.
go back to reference Lee CH, Lim J, Low A, Tan HC, Lim YT. Late angiographic stent thrombosis of polymer based paclitaxel eluting stent. Heart. 2006;92(4):551–3.PubMedCrossRef Lee CH, Lim J, Low A, Tan HC, Lim YT. Late angiographic stent thrombosis of polymer based paclitaxel eluting stent. Heart. 2006;92(4):551–3.PubMedCrossRef
7.
go back to reference Ishikawa T, Mori C, Abe Y, Aramaki K, Takeda H, Tanaka Y, Sugiura T, Yagi H, Seo A, Shibata T, et al. A case report of late coronary stent thrombosis manifested as acute myocardial infarction 19 months after stenting. Jpn Heart J. 2004;45(1):147–52.PubMedCrossRef Ishikawa T, Mori C, Abe Y, Aramaki K, Takeda H, Tanaka Y, Sugiura T, Yagi H, Seo A, Shibata T, et al. A case report of late coronary stent thrombosis manifested as acute myocardial infarction 19 months after stenting. Jpn Heart J. 2004;45(1):147–52.PubMedCrossRef
8.
go back to reference Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R, Togni M, Wenaweser P, Billinger M, Seiler C, et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation. 2009;120(5):391–9.PubMedCrossRef Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R, Togni M, Wenaweser P, Billinger M, Seiler C, et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation. 2009;120(5):391–9.PubMedCrossRef
9.
go back to reference Mintz GS, Weissman NJ, Fitzgerald PJ. Intravascular ultrasound assessment of the mechanisms and results of brachytherapy. Circulation. 2001;104(11):1320–5.PubMedCrossRef Mintz GS, Weissman NJ, Fitzgerald PJ. Intravascular ultrasound assessment of the mechanisms and results of brachytherapy. Circulation. 2001;104(11):1320–5.PubMedCrossRef
10.
go back to reference Kozuma K, Costa MA, Sabate M, Serrano P, van der Giessen WJ, Ligthart JM, Coen VL, Levendag PC, Serruys PW. Late stent malposition occurring after intracoronary beta-irradiation detected by intravascular ultrasound. J Invasive Cardiol. 1999;11(10):651–5.PubMed Kozuma K, Costa MA, Sabate M, Serrano P, van der Giessen WJ, Ligthart JM, Coen VL, Levendag PC, Serruys PW. Late stent malposition occurring after intracoronary beta-irradiation detected by intravascular ultrasound. J Invasive Cardiol. 1999;11(10):651–5.PubMed
11.
go back to reference Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG, Leon MB, Moses JW, Bonneau HN, Fitzgerald PJ. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol. 2005;46(6):1002–5.PubMedCrossRef Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG, Leon MB, Moses JW, Bonneau HN, Fitzgerald PJ. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol. 2005;46(6):1002–5.PubMedCrossRef
12.
go back to reference Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, Bonnier J, Lablanche JM, Siminiak T, Nordrehaug J, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation. 2005;111(7):900–5.PubMedCrossRef Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, Bonnier J, Lablanche JM, Siminiak T, Nordrehaug J, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation. 2005;111(7):900–5.PubMedCrossRef
13.
go back to reference Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115(18):2426–34.PubMedCrossRef Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115(18):2426–34.PubMedCrossRef
14.
go back to reference FDA advises physicians of adverse events associated with Cordis Cypher coronary stents. US Food and Drug Administration Public Health Web Notification; 2003, p. T03–71. FDA advises physicians of adverse events associated with Cordis Cypher coronary stents. US Food and Drug Administration Public Health Web Notification; 2003, p. T03–71.
15.
go back to reference Hoffmann R, Morice MC, Moses JW, Fitzgerald PJ, Mauri L, Breithardt G, Schofer J, Serruys PW, Stoll HP, Leon MB. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials. Heart. 2008;94(3):322–8.PubMedCrossRef Hoffmann R, Morice MC, Moses JW, Fitzgerald PJ, Mauri L, Breithardt G, Schofer J, Serruys PW, Stoll HP, Leon MB. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials. Heart. 2008;94(3):322–8.PubMedCrossRef
16.
go back to reference Hassan AK, Bergheanu SC, Stijnen T, van der Hoeven BL, Snoep JD, Plevier JW, Schalij MJ, Wouter Jukema J. Late stent malposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J. 2010;31(10):1172–80. Hassan AK, Bergheanu SC, Stijnen T, van der Hoeven BL, Snoep JD, Plevier JW, Schalij MJ, Wouter Jukema J. Late stent malposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J. 2010;31(10):1172–80.
17.
go back to reference Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation. 2003;108(14):1701–6.PubMedCrossRef Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation. 2003;108(14):1701–6.PubMedCrossRef
Metadata
Title
The potential of surgical strategy for incomplete stent apposition after implantation of a sirolimus eluting stent
Authors
Toshiyuki Nagai
Masaru Shibata
Satoru Suzuki
Takashi Matsubara
Publication date
01-05-2011
Publisher
Springer Japan
Published in
Cardiovascular Intervention and Therapeutics / Issue 2/2011
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-010-0047-7

Other articles of this Issue 2/2011

Cardiovascular Intervention and Therapeutics 2/2011 Go to the issue